422 related articles for article (PubMed ID: 9916747)
1. Identification of HLA-A3 and -B7-restricted CTL response to hepatitis C virus in patients with acute and chronic hepatitis C.
Chang KM; Gruener NH; Southwood S; Sidney J; Pape GR; Chisari FV; Sette A
J Immunol; 1999 Jan; 162(2):1156-64. PubMed ID: 9916747
[TBL] [Abstract][Full Text] [Related]
2. Relation between viral fitness and immune escape within the hepatitis C virus protease.
Söderholm J; Ahlén G; Kaul A; Frelin L; Alheim M; Barnfield C; Liljeström P; Weiland O; Milich DR; Bartenschlager R; Sällberg M
Gut; 2006 Feb; 55(2):266-74. PubMed ID: 16105887
[TBL] [Abstract][Full Text] [Related]
3. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
López-Labrador FX; He XS; Berenguer M; Cheung RC; González-Candelas F; Wright TL; Greenberg HB
J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
[TBL] [Abstract][Full Text] [Related]
4. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
Wang Y; Takao Y; Harada M; Komatsu N; Ono T; Sata M; Itoh K; Yamada A
Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
[TBL] [Abstract][Full Text] [Related]
5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
Nayersina R; Fowler P; Guilhot S; Missale G; Cerny A; Schlicht HJ; Vitiello A; Chesnut R; Person JL; Redeker AG; Chisari FV
J Immunol; 1993 May; 150(10):4659-71. PubMed ID: 7683326
[TBL] [Abstract][Full Text] [Related]
6. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
Borghan MA; Oka S; Takiguchi M
Tissue Antigens; 2005 Oct; 66(4):305-13. PubMed ID: 16185326
[TBL] [Abstract][Full Text] [Related]
7. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
Kawashima I; Tsai V; Southwood S; Takesako K; Sette A; Celis E
Cancer Res; 1999 Jan; 59(2):431-5. PubMed ID: 9927058
[TBL] [Abstract][Full Text] [Related]
8. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
Hiroishi K; Kita H; Kojima M; Okamoto H; Moriyama T; Kaneko T; Ishikawa T; Ohnishi S; Aikawa T; Tanaka N; Yazaki Y; Mitamura K; Imawari M
Hepatology; 1997 Mar; 25(3):705-12. PubMed ID: 9049223
[TBL] [Abstract][Full Text] [Related]
9. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
Shirai M; Arichi T; Nishioka M; Nomura T; Ikeda K; Kawanishi K; Engelhard VH; Feinstone SM; Berzofsky JA
J Immunol; 1995 Mar; 154(6):2733-42. PubMed ID: 7533182
[TBL] [Abstract][Full Text] [Related]
10. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
Urbani S; Uggeri J; Matsuura Y; Miyamura T; Penna A; Boni C; Ferrari C
Hepatology; 2001 Jun; 33(6):1533-43. PubMed ID: 11391544
[TBL] [Abstract][Full Text] [Related]
11. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
Lu J; Celis E
Cancer Res; 2000 Sep; 60(18):5223-7. PubMed ID: 11016651
[TBL] [Abstract][Full Text] [Related]
12. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
Guo HZ; Wang WL; Wang T
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May; 20(3):325-7. PubMed ID: 15193229
[TBL] [Abstract][Full Text] [Related]
13. HLA-A1 and HLA-A3 T cell epitopes derived from influenza virus proteins predicted from peptide binding motifs.
DiBrino M; Tsuchida T; Turner RV; Parker KC; Coligan JE; Biddison WE
J Immunol; 1993 Dec; 151(11):5930-5. PubMed ID: 7504010
[TBL] [Abstract][Full Text] [Related]
14. Development of a DNA vaccine designed to induce cytotoxic T lymphocyte responses to multiple conserved epitopes in HIV-1.
Wilson CC; McKinney D; Anders M; MaWhinney S; Forster J; Crimi C; Southwood S; Sette A; Chesnut R; Newman MJ; Livingston BD
J Immunol; 2003 Nov; 171(10):5611-23. PubMed ID: 14607970
[TBL] [Abstract][Full Text] [Related]
15. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
Wong DK; Dudley DD; Afdhal NH; Dienstag J; Rice CM; Wang L; Houghton M; Walker BD; Koziel MJ
J Immunol; 1998 Feb; 160(3):1479-88. PubMed ID: 9570570
[TBL] [Abstract][Full Text] [Related]
16. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
Nakamoto Y; Kaneko S; Takizawa H; Kikumoto Y; Takano M; Himeda Y; Kobayashi K
J Med Virol; 2003 May; 70(1):51-61. PubMed ID: 12629644
[TBL] [Abstract][Full Text] [Related]
17. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
Martin P; Parroche P; Chatel L; Barretto C; Beck A; Trépo C; Bain C; Lone YC; Inchauspé G; Fournillier A
J Med Virol; 2004 Nov; 74(3):397-405. PubMed ID: 15368525
[TBL] [Abstract][Full Text] [Related]
18. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
Lim WC; Khan AM
BMC Genomics; 2018 Jan; 19(Suppl 1):42. PubMed ID: 29363421
[TBL] [Abstract][Full Text] [Related]
19. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
Lamonaca V; Missale G; Urbani S; Pilli M; Boni C; Mori C; Sette A; Massari M; Southwood S; Bertoni R; Valli A; Fiaccadori F; Ferrari C
Hepatology; 1999 Oct; 30(4):1088-98. PubMed ID: 10498664
[TBL] [Abstract][Full Text] [Related]
20. A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
Niu Y; Komatsu N; Komohara Y; Matsueda S; Yutani S; Ishihara Y; Itou M; Yamada A; Itoh K; Shichijo S
J Med Virol; 2009 Jul; 81(7):1232-40. PubMed ID: 19475615
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]